CY2079B1 - Method for introducing a 1,2 double bond into azasteroids - Google Patents

Method for introducing a 1,2 double bond into azasteroids

Info

Publication number
CY2079B1
CY2079B1 CY9802079A CY9802079A CY2079B1 CY 2079 B1 CY2079 B1 CY 2079B1 CY 9802079 A CY9802079 A CY 9802079A CY 9802079 A CY9802079 A CY 9802079A CY 2079 B1 CY2079 B1 CY 2079B1
Authority
CY
Cyprus
Prior art keywords
azasteroids
introducing
double bond
bond
double
Prior art date
Application number
CY9802079A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CY2079B1 publication Critical patent/CY2079B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CY9802079A 1989-11-13 1998-10-16 Method for introducing a 1,2 double bond into azasteroids CY2079B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/434,663 US5021575A (en) 1989-11-13 1989-11-13 Method for introducing a 1,2 double bond into azasteroids

Publications (1)

Publication Number Publication Date
CY2079B1 true CY2079B1 (en) 1998-10-16

Family

ID=23725148

Family Applications (2)

Application Number Title Priority Date Filing Date
CY9802079A CY2079B1 (en) 1989-11-13 1998-10-16 Method for introducing a 1,2 double bond into azasteroids
CY0000051A CY2199B1 (en) 1989-11-13 2000-10-27 Method for introducing a 1,2 double bond into 4-azasteroids and crystalline phroscor (R) and pharma ceutical compositions thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY0000051A CY2199B1 (en) 1989-11-13 2000-10-27 Method for introducing a 1,2 double bond into 4-azasteroids and crystalline phroscor (R) and pharma ceutical compositions thereof

Country Status (8)

Country Link
US (1) US5021575A (de)
EP (2) EP0655459B1 (de)
JP (1) JPH0651718B2 (de)
CA (1) CA2029859C (de)
CY (2) CY2079B1 (de)
DE (2) DE69022540T2 (de)
HK (1) HK1002708A1 (de)
LV (1) LV12572B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571817A (en) * 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
US5120847A (en) * 1990-08-27 1992-06-09 Merck & Co., Inc. Process for iodinating or brominating the α-methylenic carbon of a secondary amide
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
CA2084799C (en) 1991-12-17 2003-01-28 Glenn J. Gormley Method of prevention of prostatic carcinoma with 17 beta-n-monosubstituted-carbamoyl-4-aza-5 alpha-androst-1 -en-3-ones
EP0547687A1 (de) * 1991-12-18 1993-06-23 Merck & Co. Inc. 17-Beta-substituierte Adamantyl/Norbornanyl Carbamoyl-4-Aza-5-Alpha-Androsta-1-En-3-Onen und Androstan-3-Onen
ATE165368T1 (de) * 1991-12-20 1998-05-15 Glaxo Wellcome Inc Inhibitoren von testosteron-5-alpha reductase.
US5302589A (en) * 1992-08-07 1994-04-12 Glaxo, Inc. Heterocyclic inhibitors of 5-α-testosterone reductase
US5468860A (en) * 1992-11-19 1995-11-21 Merck & Co., Inc. New finasteride processes
US5359071A (en) * 1993-03-12 1994-10-25 Merck & Co., Inc. 15-substituted 4-azasteroids
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5817818A (en) * 1994-09-16 1998-10-06 Glaxo Wellcome Inc. Androstenones
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US6001844A (en) 1995-09-15 1999-12-14 Merck & Co., Inc. 4-Azasteroids for treatment of hyperandrogenic conditions
US6365597B1 (en) 1996-02-14 2002-04-02 Aventis Pharmaceuticals Inc. 4-aza steroids
AUPO533497A0 (en) 1997-02-21 1997-03-20 Frontier Tower Pty Ltd Self-adhesive decorative devices
US6187925B1 (en) 1997-12-23 2001-02-13 Merck & Co., Inc. Intermediates and process for the synthesis of azasteroids
US5998427A (en) * 1998-05-14 1999-12-07 Glaxo Wellcome Inc. Androstenones
JP2004508380A (ja) * 2000-09-07 2004-03-18 ドクター・レディーズ・ラボラトリーズ・リミテッド １７−β−（Ｎ−ｔｅｒ−ブチルカルバモイル）−４−アザ−５−α−アンドロスト−１−エン−３−オンの新規の多形体及びその調製方法
KR20030029947A (ko) 2000-09-07 2003-04-16 닥터 레디스 레보러터리즈 리미티드 17-β-(엔-티-부틸카르바모일)-4-아자-5-α-안드로스트-1-엔-3-온의 신규의다형태 및 그 제조방법
SK2732003A3 (en) * 2000-09-07 2004-01-08 Reddys Lab Ltd Dr Novel polymorphic form of 17-beta-(N-ter.butyl carbamoyl)-4-aza- 5-alpha-androst-1-en-3-one and a process for preparing it
US6645974B2 (en) 2001-07-31 2003-11-11 Merck & Co., Inc. Androgen receptor modulators and methods for use thereof
ES2185503B1 (es) * 2001-09-29 2004-08-01 Ragactives, S.L. Procedimiento para la obtencion de 17beta-(sustituido)-3-oxoalfa1,2-4-azaesteroides e intermedios.
HU227117B1 (en) 2002-05-10 2010-07-28 Richter Gedeon Nyrt Process for dehydrogenation of aza-androstane compounds
KR100872722B1 (ko) * 2002-06-28 2008-12-05 주식회사 중외제약 피나스테라이드의 제조방법
CN1319985C (zh) 2002-07-16 2007-06-06 西格弗里德杰耐克斯国际两合公司 3－氧代－4－氮杂甾族化合物引入1,2－双键的方法
ES2206065B1 (es) 2002-10-31 2005-08-16 Ragactives, S.L. Procedimiento para la obtencion de la forma polimorfica i de finasterida.
KR100508019B1 (ko) 2003-07-19 2005-08-17 한미약품 주식회사 고순도 1-안드로스텐 유도체의 제조 방법
DE502004007503D1 (de) * 2003-07-21 2008-08-14 Siegfried Generics Int Ag Verfahren zur herstellung von alpha, beta-ungesattigten ami dverbindungen
WO2005066196A1 (en) * 2003-12-30 2005-07-21 Ranbaxy Laboratories Limited Amorphous form of finasteride and processes for its preparation
US7531658B2 (en) * 2006-01-20 2009-05-12 Apotex Pharmachem Inc. Process for the preparation of 17-N-substituted-carbamoyl-4-aza-androst-1-en-3-ones
HU230730B1 (hu) 2011-06-30 2017-12-28 Richter Gedeon Nyrt Eljárás (5alfa,17béta)-N-[2,5-bisz-(trifluormetil)-fenil]-3-oxo-4-aza-5-androszt-1-én-17-karbonsavamid előállítására

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4220775A (en) * 1979-03-15 1980-09-02 Merck & Co., Inc. Preparation of 4-aza-17-substituted-5α-androstan-3-ones useful as 5α-reductase inhibitors
IL74365A (en) * 1984-02-27 1990-07-26 Merck & Co Inc 17beta-(n-t.-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one and pharmaceutical compositions containing it
NZ225100A (en) * 1987-06-29 1991-09-25 Merck & Co Inc Reaction of steroids (including 4-azasteroids) with a silylating agent in the presence of a quinone to introduce a delta' double bond and silylated intermediates

Also Published As

Publication number Publication date
EP0655459A2 (de) 1995-05-31
EP0655459A3 (de) 1996-05-22
CY2199B1 (en) 2002-11-08
EP0428366A2 (de) 1991-05-22
LV12572A (en) 2000-11-20
EP0428366A3 (en) 1992-07-29
JPH0651718B2 (ja) 1994-07-06
JPH03206096A (ja) 1991-09-09
EP0655459B1 (de) 2000-05-03
DE69022540D1 (de) 1995-10-26
DE69022540T2 (de) 1996-05-02
US5021575A (en) 1991-06-04
CA2029859A1 (en) 1991-05-14
CA2029859C (en) 2002-05-14
DE69033538T2 (de) 2001-01-04
EP0428366B1 (de) 1995-09-20
HK1002708A1 (en) 1998-09-11
LV12572B (en) 2001-04-20
DE69033538D1 (de) 2000-06-08

Similar Documents

Publication Publication Date Title
EP0428366A3 (en) Method for introducing a 1,2 double bond into azasteroids
IL89712A0 (en) Method for producing 2'''-o-demethyltylosin
GR3017383T3 (en) Method for strengthening a panel.
HUT52050A (en) Process for producing 1,4-disubstituted-piperidinyl-derivatives
PL279610A1 (en) Method for manufacturing 1,3-diols
AR244090A1 (es) Metodo para producir preparaciones de etoposido
GB8910302D0 (en) Bonding method
EP0319915A3 (en) Method for producing 4,4'-dibromobiphenyl
YU46689A (en) Process for making 1,4-dihydro-pyridinic derivatives
HU903922D0 (en) Process for producing 1,1-dioxipenicillin-naoyl-oxymethyl d-6-[-(methylenamino) phenylacetic] penicillinate preparatives
HU9200020D0 (en) Process for producing 2,4,6 trifluoro-triazine
GB2163176B (en) A process for producing a 1,4-dialkylbenzene
EP0593452A4 (de) Verfahren zur herstellung eines mit metallradionuklid markierten proteins.
HUT53898A (en) Process for producing 2,4-diamino-6-piperidinyl-3-n-oxide
EP0234820A3 (en) A process for producing 0,0-dilower-alkylchlorothiophosphate
GR900100777A (en) Improved method for useful diazinylpiperidines
GB8914748D0 (en) New method
PL268010A1 (en) Method for manufacturing 2-acetylamine-1,3,4-thiodiazolo-5-sulphonamid
PL275247A2 (en) Method for manufacturing 2,8-dihydroxy-6-menthene
PL286928A1 (en) Method for manufacturing a new 3,6,8-p-methentriol
PL265803A2 (en) A method for producing the new compound 3,17,20 - trioxa-2,19-dokozandion
RO101116B1 (en) 2,4-dinitro-6-sec-buthyl-phenyl crizantemate production method
RO101588B1 (ro) Procedeu pentru obtinerea 2,6-di-tert-butil-4-aminofenolului
GR900100205A (en) 1,4-dihydropyridine preparation method
HUT50119A (en) Process for producing 3-/3,4,5,6-tetrahydro-phtalimido/-benzaldehydes